Well-regarded for its ‘business minded, practical advice’ and ’pragmatic’ approach, Goodwin continues to feature prominently on complex U.S. merger reviews, particularly for private equity, technology and life sciences clients, where transactions often raise novel issues and attract scrutiny from the DOJ and FTC alongside parallel review overseas. Andrew Lacy co-leads the antitrust practice, and is a go-to for transaction-driven antitrust risk, advising on HSR strategy, cross-border filing obligations and agency engagement before the DOJ, FTC and state regulators, alongside Arman Oruc, who is frequently engaged by private equity sponsors and public companies. Paul Jin is a key name for complex HSR filings, while Simone Waterbury in Boston is frequently instructed on cross-border transactions. All Attorneys are based in Washington DC unless otherwise stated.
Legal 500 Editorial commentary
Accolades
Client satisfaction: Lawyer & team quality
Testimonials
Collated independently by Legal 500 research team.
- ‘Andrew Lacy is very pragmatic and responsive. He gives direct, business minded, practical advice in a field that can be overwhelmed by theory.’
- ‘Very pragmatic and responsive. Business minded, practical advice.’
- ‘The Goodwin team's key strength is its members. The attorneys are highly communicative and always professional. We felt informed and confident every step of the way. The team utilized common sense layman's terms when speaking with each member of our business team.'
- 'The collaborative aspect of Goodwin's Merger control practice is simply the best I have experienced.'
Key clients
- Arlington Capital Partners / BlueHalo
- Webster Equity Partners / Retina Consultants of America
- Vicebio Limited
- Fuze Health (f/k/a LetsGetChecked)
- Teleflex Inc.
- Freenome
- SpringWorks Therapeutics
- Septerna, Inc.
- Enfusion
- SevenRooms
- LumiThera
- Federici Brand (Color Wow)
Work highlights
Represented Arlington Capital Partners and its portfolio company BlueHalo in its definitive agreement to be acquired by AeroVironment in an all-stock transaction with an enterprise value of approximately US$4.1 billion.
Represented Webster Equity Partners and its portfolio company Retina Consultants of America (“RCA”) in its definitive agreement to be acquired by Cencora in a transaction with an enterprise value of approximately US$4.6 billion.
Represented Vicebio in its sale to Sanofi.
Practice head
Andrew Lacy; Arman Oruc
Other key lawyers
Paul Jin; John Goheen; Simone Waterbury; Elliot Silver